These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23295831)

  • 1. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer.
    Ying L; Huang Y; Chen H; Wang Y; Xia L; Chen Y; Liu Y; Qiu F
    Mol Biosyst; 2013 Mar; 9(3):407-11. PubMed ID: 23295831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis.
    Qin R; Chen Z; Ding Y; Hao J; Hu J; Guo F
    Neoplasma; 2013; 60(5):486-92. PubMed ID: 23790166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.
    Wang P; Ren Z; Sun P
    J Cell Biochem; 2012 Jun; 113(6):1868-74. PubMed ID: 22234798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.
    Luo M; Li Z; Wang W; Zeng Y; Liu Z; Qiu J
    FEBS J; 2013 Apr; 280(7):1709-16. PubMed ID: 23399020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
    Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
    J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.
    Xiu YL; Sun KX; Chen X; Chen S; Zhao Y; Guo QG; Zong ZH
    Oncotarget; 2017 May; 8(19):31714-31725. PubMed ID: 28423647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
    Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
    Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
    Takahashi H; Nakatsuji H; Takahashi M; Avirmed S; Fukawa T; Takemura M; Fukumori T; Kanayama H
    Urology; 2012 Jan; 79(1):240.e1-8. PubMed ID: 22119253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.
    Ying L; Chen Q; Wang Y; Zhou Z; Huang Y; Qiu F
    Mol Biosyst; 2012 Sep; 8(9):2289-94. PubMed ID: 22722759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells.
    Zhang Y; Zou Y; Wang W; Zuo Q; Jiang Z; Sun M; De W; Sun L
    J Cell Biochem; 2015 Apr; 116(4):542-50. PubMed ID: 25358633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
    Wang Y; Chen W; Yang C; Wu W; Wu S; Qin X; Li X
    Int J Oncol; 2012 Jul; 41(1):276-84. PubMed ID: 22576688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA MEG3 contributes to cisplatin‑induced apoptosis via inhibition of autophagy in human glioma cells.
    Ma B; Gao Z; Lou J; Zhang H; Yuan Z; Wu Q; Li X; Zhang B
    Mol Med Rep; 2017 Sep; 16(3):2946-2952. PubMed ID: 28677749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
    Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
    Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
    Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
    Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
    FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.